Drug intelligence / Profile preview

Yangshen Buxue Granules

Development stage: Unknown
Lead developer: Red Coral Pharmaceutical
Administration: Oral

Overview

Yangshen Buxue Granules (养肾补血颗粒) is a Traditional Chinese Medicine (TCM) therapeutic developed and manufactured by Guangdong Hongshanhu Pharmaceutical. Formulated as oral granules, the product is indicated for the treatment of kidney deficiency and blood deficiency. In the framework of TCM, these conditions are associated with symptoms such as dizziness, fatigue, palpitations, and soreness of the waist and knees. The drug is approved for marketing in China and functions as a tonifying agent to replenish vital energy and blood.

Brand names: Yangshen Buxue Granules养肾补血颗粒
Other names: Yangshen Buxue Keli养肾补血颗粒

Beyond the preview

Go deeper on Yangshen Buxue Granules.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Yangshen Buxue Granules.

Explore the full profile